Drug Index
MYCOSTATIN
Generic: NYSTATIN
Marketing status: Discontinued
- Route: TOPICAL
- Class: Cardiovascular
- Safety profile: generic
- Latest regulatory update: 17 Sept 1998, 12:00 am (UTC)
Structured Monograph
Approval overview MYCOSTATIN is listed in Drugs@FDA under application 060578 (ANDA). Marketing status: Discontinued Active ingredient NYSTATIN Form and strength POWDER;TOPICAL - 100,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor DELCOR ASSET CORP Submission history Latest submission status date: 1998-09-17 00:00:00. Submission type: SUPPL.